• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

In vivo analysis of influenza A mRNA secondary structures identifies critical regulatory motifs

tetano

Editor, Senior Moderator
Nucleic Acids Res. 2019 May 4. pii: gkz318. doi: 10.1093/nar/gkz318. [Epub ahead of print]
[h=1]In vivo analysis of influenza A mRNA secondary structures identifies critical regulatory motifs.[/h] Simon LM[SUP]1[/SUP], Morandi E[SUP]1[/SUP], Luganini A[SUP]1[/SUP], Gribaudo G[SUP]1[/SUP], Martinez-Sobrido L[SUP]2[/SUP], Turner DH[SUP]3[/SUP], Oliviero S[SUP]1[/SUP], Incarnato D[SUP]1,[/SUP][SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The influenza A virus (IAV) is a continuous health threat to humans as well as animals due to its recurring epidemics and pandemics. The IAV genome is segmented and the eight negative-sense viral RNAs (vRNAs) are transcribed into positive sense complementary RNAs (cRNAs) and viral messenger RNAs (mRNAs) inside infected host cells. A role for the secondary structure of IAV mRNAs has been hypothesized and debated for many years, but knowledge on the structure mRNAs adopt in vivo is currently missing. Here we solve, for the first time, the in vivo secondary structure of IAV mRNAs in living infected cells. We demonstrate that, compared to the in vitro refolded structure, in vivo IAV mRNAs are less structured but exhibit specific locally stable elements. Moreover, we show that the targeted disruption of these high-confidence structured domains results in an extraordinary attenuation of IAV replicative capacity. Collectively, our data provide the first comprehensive map of the in vivo structural landscape of IAV mRNAs, hence providing the means for the development of new RNA-targeted antivirals.
? The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.


PMID: 31053845 DOI: 10.1093/nar/gkz318
 
Back
Top Bottom